Why Agenus Stock Sank on Tuesday

Even on a generally downbeat day for the stock market, Agenus (NASDAQ: AGEN) was quite a downer on Tuesday. The biotech company's shares fell by just over 6% on the day because of a notable C-suite departure.

Agenus announced in a tersely worded regulatory filing that chief legal and compliance officer Adam Krauss has served notice that he will be vacating his position, effective this Friday, July 30.

Image source: Getty Images.

Continue reading

Source Fool.com